Skip to main content

Table 2 PC-594 statistical performance in USA Caucasian populations

From: Metabolic system alterations in pancreatic cancer patient serum: potential for early detection

Cohort Mean PC-594 (ug/ml CAE) ±1SEM p versus PC ROC-AUC versus PC (95% CI)
USA control 1    
  30-39 yrs 2.85 ±0.14 4.8E-09 0.99 (0.98-1.0)
  40-49 yrs 2.58 ±0.09 5.7E-07 0.97 (0.96-0.98)
  50-59 yrs 2.44 ±0.12 1.8E-05 0.97 (0.96-0.98)
  60-69 yrs 1.77 ±0.10 1.9E-05 0.91 (0.89-0.93)
  70-80 yrs 1.69 ±0.09 7.9E-04 0.90 (0.88-0.92)
  All yrs 2.23 ±0.05 6.2E-05 0.94 (0.93-0.96)
USA control 2 2.15 ±0.20 5.9E-06 0.97 (0.95-0.99)
USA IMPN 0.95 ±0.19 0.003 -
USA PC 0.43 ±0.06 - -